Annual EBITDA
$9.11B$410.22M+4.71%
Summary
- Current Value
- As of today, TAK annual EBITDA is $9.11B, up +4.71% on
- Historical Performance
- TAK annual EBITDA is down -14.23% over the past 3 years, and up +11.77% over the past 5 years
- All-Time High Comparison
- TAK annual EBITDA is currently -14.23% below its historical high of $10.62B set on
- 3-Year Low Comparison
- TAK annual EBITDA is +4.71% above its 3-year low of $8.70B reached on
- Sector Comparison
- TAK annual EBITDA is higher than 98.56% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $9.11B | +4.7% | -14.2% | +11.8% | +58.1% | |
| Quarterly EBITDA | $2.15B | -17.1% | -6.7% | -4.7% | +30.6% | |
| TTM EBITDA | $8.40B | -7.6% | -8.1% | -4.3% | +47.6% | |
| Price | $15.90 | +19.1% | +2.0% | -11.2% | -33.1% | |
| PE Ratio | 201.78 | +542.6% | +728.3% | +511.4% | +1483.8% | |
| Annual Revenue | $30.05B | +1.9% | -5.4% | -0.7% | +90.4% | |
| Annual EPS | $0.22 | -30.0% | -66.0% | +69.8% | -89.1% | |
| Annual EBIT | $4.12B | +12.3% | -24.2% | +47.9% | -9.0% | |
| Annual Net Income | $709.37M | -28.9% | -65.4% | +74.1% | -78.0% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $10.62B | N/A | -14.2% |
| 5Y | $10.62B | -14.2% | |
| All | $10.62B | -14.2% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $8.70B | +4.7% | |
| 5Y | $8.15B | N/A | +11.8% |
| All | $572.38M | +1491.7% |
EBITDA History
FAQ
What is the current annual EBITDA of TAK?
As of today, TAK annual EBITDA is $9.11B
What is 1-year change in TAK annual EBITDA?
TAK annual EBITDA is up +4.71% year-over-year
What is 3-year change in TAK annual EBITDA?
TAK annual EBITDA is down -14.23% over the past 3 years
How far is TAK annual EBITDA from its all-time high?
TAK annual EBITDA is currently -14.23% below its historical high of $10.62B set on March 31, 2022
How does TAK annual EBITDA rank versus sector peers?
TAK annual EBITDA is higher than 98.56% of companies in Healthcare sector
When is TAK next annual earnings release?
As of today, the next annual earnings release for TAK has not been scheduled
Quarterly EBITDA
$2.15B$421.84M-16.37%
Summary
- Current Value
- As of today, TAK quarterly EBITDA is $2.15B, down -16.37% on
- Historical Performance
- TAK quarterly EBITDA is down -17.12% year-over-year, and down -6.71% over the past 3 years
- All-Time High Comparison
- TAK quarterly EBITDA is currently -41.97% below its historical high of $3.71B set on
- 3-Year Low Comparison
- TAK quarterly EBITDA is +49.08% above its 3-year low of $1.45B reached on
- Sector Comparison
- TAK quarterly EBITDA is higher than 98.19% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $2.15B | -16.4% | -17.1% | -6.7% | -4.7% | |
| Annual EBITDA | $9.11B | – | +4.7% | -14.2% | +11.8% | |
| TTM EBITDA | $8.40B | -5.0% | -7.6% | -8.1% | -4.3% | |
| Price | $15.90 | +10.0% | +19.1% | +2.0% | -11.2% | |
| PE Ratio | 201.78 | +10.0% | +542.6% | +728.3% | +511.4% | |
| Quarterly Revenue | $7.55B | -1.5% | -4.3% | +4.1% | +1.5% | |
| Quarterly EPS | -$0.03 | -109.3% | -113.2% | -117.7% | -309.1% | |
| Quarterly EBIT | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| Quarterly Net Income | -$79.53M | -109.3% | -112.9% | -117.8% | -307.4% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $2.58B | -16.4% | |
| 3Y | $2.68B | -19.6% | |
| 5Y | $3.71B | -42.0% | |
| All | $3.71B | -42.0% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.45B | +49.1% | |
| 3Y | $1.45B | +49.1% | |
| 5Y | $1.45B | +49.1% | |
| All | -$1.91B | +212.8% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of TAK?
As of today, TAK quarterly EBITDA is $2.15B
What is TAK quarterly EBITDA most recent change?
TAK quarterly EBITDA was down -16.37% on September 1, 2025
What is 1-year change in TAK quarterly EBITDA?
TAK quarterly EBITDA is down -17.12% year-over-year
How far is TAK quarterly EBITDA from its all-time high?
TAK quarterly EBITDA is currently -41.97% below its historical high of $3.71B set on June 30, 2021
How does TAK quarterly EBITDA rank versus sector peers?
TAK quarterly EBITDA is higher than 98.19% of companies in Healthcare sector
When is TAK next earnings release?
The next earnings release for TAK is on
TTM EBITDA
$8.40B$445.06M-5.03%
Summary
- Current Value
- As of today, TAK TTM EBITDA is $8.40B, down -5.03% on
- Historical Performance
- TAK TTM EBITDA is down -7.56% year-over-year, and down -8.09% over the past 3 years
- All-Time High Comparison
- TAK TTM EBITDA is currently -21.05% below its historical high of $10.64B set on
- 3-Year Low Comparison
- TAK TTM EBITDA is +1.15% above its 3-year low of $8.30B reached on
- Sector Comparison
- TAK TTM EBITDA is higher than 98.10% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $8.40B | -5.0% | -7.6% | -8.1% | -4.3% | |
| Annual EBITDA | $9.11B | – | +4.7% | -14.2% | +11.8% | |
| Quarterly EBITDA | $2.15B | -16.4% | -17.1% | -6.7% | -4.7% | |
| Price | $15.90 | +10.0% | +19.1% | +2.0% | -11.2% | |
| PE Ratio | 201.78 | +10.0% | +542.6% | +728.3% | +511.4% | |
| TTM Revenue | $29.63B | -1.1% | -2.0% | -1.8% | -0.8% | |
| TTM EPS | $0.08 | -73.3% | -86.9% | -85.2% | -52.8% | |
| TTM EBIT | $2.51B | -34.3% | -37.8% | -38.7% | -34.9% | |
| TTM Net Income | $260.53M | -72.8% | -86.5% | -84.4% | -50.4% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $9.08B | N/A | -7.5% |
| 3Y | $9.52B | -11.8% | |
| 5Y | $10.64B | -21.1% | |
| All | $10.64B | -21.1% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $8.40B | at low | |
| 3Y | $8.30B | +1.1% | |
| 5Y | $8.30B | +1.1% | |
| All | -$38.80M | >+9999.0% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of TAK?
As of today, TAK TTM EBITDA is $8.40B
What is TAK TTM EBITDA most recent change?
TAK TTM EBITDA was down -5.03% on September 1, 2025
What is 1-year change in TAK TTM EBITDA?
TAK TTM EBITDA is down -7.56% year-over-year
How far is TAK TTM EBITDA from its all-time high?
TAK TTM EBITDA is currently -21.05% below its historical high of $10.64B set on September 30, 2021
How does TAK TTM EBITDA rank versus sector peers?
TAK TTM EBITDA is higher than 98.10% of companies in Healthcare sector
When is TAK next earnings release?
The next earnings release for TAK is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- TAK Official Website www.takeda.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1395064/000139506425000095/0001395064-25-000095-index.htm
- TAK Profile on Yahoo Finance finance.yahoo.com/quote/TAK
- TAK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/tak